| ²é¿´: 8281 | »Ø¸´: 290 | ||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | ||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||
zhwenxingľ³æ (ÖøÃûдÊÖ)
|
[×ÊÔ´]
¡ø¡ø¡ø»¹ÊÇÖØ°õ³ö»÷£¡¡ª¡ªCellÔÓÖ¾ÆÀ³öµÄ10ƪÎÄÕ£¡È«²¿È«²Êpdf£¡
|
|
|
ÇëÄú¿´Ò»ÑÛ£º 1¡¢Ê×ÏÈÎÒ»¹ÊǼá³ÖÃâ·ÑÌṩÏÂÔØ£¬ÎªÁ˺ö࿴²»µ½CELLÎÄÕµijæÓÑÃÇ£¡ 2¡¢ÉúÎïÉúÃü¿ÆÑ§ÁìÓòµÄ³æÓÑ£¬¿´ÕâÖÖÅ£Îij¤¼ûʶ£¡ ÎÞÂÛÄú¸ø²»¸øºÃÆÀ£¬Ö»Òª¶ÔÄúÓаïÖúÁ˾ÍÊǶÔ×ÊÔ´µÄÁ¼ºÃÀûÓᣠ¸Ðл³æÓÑÖ§³Ö£¡ ÒÔºóÈÔÈ»¼á³Ö·¢Ãâ·ÑµÄ×ÊÔ´Ìû¡£ÍûÖÚλ³æÓÑÖ§³Ö¡£ ÄÉÃ×ÅÌÏÂÔØµØÖ·£¨ÄÉÃ×Å̺ÃÏñ²»ÊǺÜÎȶ¨£¬ÏÂÔØ²»µ½µÄ³æÓѲ»ÒªËµÁ¬½ÓÎÊÌ⣬ҲÐíÄú»»¸öʱ¼ä¶Î¾Í¿ÉÒÔÁË¡£Èç¹ûÕæµÄ²»ÄÜÏÂÔØÎÒ»á¸üÐÂÁ¬½Ó.Thanks...£© С¹Ü£¬ÍøËÙÂý£¬´óÎļþ£¬À´Ö®²»Òס£ ÄÉÃ×ÅÌ http://www.namipan.com/d/Cell%20 ... f7c6064238ef60cc500 ´ËÄÉÃ×ÅÌÁ¬½Ó2009Äê1ÔÂ10ÈÕ21£º00ÑéÖ¤£¬Ã»ÓÐʧЧ£¡£¡£¡ ÐÂÔöbrsboxÏÂÔØµØÖ·£º http://www.brsbox.com/filebox/do ... 30e843450f32c820553 ÍùÍù¾ÍÊÇÕâÑù£¬Óв»µ½10%µÄÈË£¬¼´10¸öÈËÖÐÒ²ÐíÖ»ÓÐÒ»¸ö¸ß̧¹óÊÖ¶Ô·¢×ÊÔ´Õ߸øÓèÁ˹ÄÀø¡£´ó¼Ò¶¼ÕâÑùÏÂÈ¥£¬×ÊÔ´¾ÍºÜÄÑÃâ·ÑÁË¡£¹þ¹þ¡£ä¯ÀÀÁËÒ»ÏÂ×ÊÔ´ÇøµÄ£¬¶¼ÕâÑù¡£Ô¸´ó¼ÒÏÂÔØÇ°Ö§³Ö£¡ [ Last edited by zhwenxing on 2009-1-10 at 20:59 ] |
» ²ÂÄãϲ»¶
0805 316Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
085601Çóµ÷¼Á×Ü·Ö293Ó¢Ò»Êý¶þ
ÒѾÓÐ3È˻ظ´
¿¼Ñе÷¼Á
ÒѾÓÐ3È˻ظ´
08¹¤Ñ§µ÷¼Á
ÒѾÓÐ17È˻ظ´
340Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
311Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
ʳƷר˶ һ־Ը˫һÁ÷ 328
ÒѾÓÐ4È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ6È˻ظ´
300·Ö£¬²ÄÁÏ£¬Çóµ÷¼Á£¬Ó¢Ò»Êý¶þ
ÒѾÓÐ5È˻ظ´
Çóµ÷¼Á£¬Ò»Ö¾Ô¸:ÄϾ©º½¿Õº½Ìì´óѧ´óѧ £¬080500²ÄÁÏ¿ÆÑ§Ó빤³Ìѧ˶£¬×Ü·Ö289·Ö
ÒѾÓÐ5È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
232Â¥2009-05-15 17:59:32
zhwenxing
ľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 11 (СѧÉú)
- ¹ó±ö: 0.005
- ½ð±Ò: 2189.8
- Ìû×Ó: 1324
- ÔÚÏß: 93.3Сʱ
- ³æºÅ: 596551
²¹È«ÐÅÏ¢£º
|
¡¶Ï¸°û¡·08Äê11ÔÂ×îÊܹØ×¢µÄʮƪÂÛÎÄ ¡¶Ï¸°û¡·´´¿¯ÓÚ1976Ä꣬ÏÖÒѳÉΪÊÀ½ç×ÔÈ»¿ÆÑ§Ñо¿ÁìÓò×îÖøÃûµÄÆÚ¿¯Ö®Ò»£¬²¢Â½Ðø·¢ÐÐÁËÊ®¼¸ÖÖæ¢Ãÿ¯£¬ÔÚ¸÷×ÔרҵÁìÓòÀï¾ùÕ¼¾ÝמÙ×ãÇáÖØµÄµØÎ»¡£¡¶Ï¸°û¡·ÒÔ·¢±í¾ßÓÐÖØÒªÒâÒåµÄÔ´´ÐÔ¿ÆÑб¨¸æÎªÖ÷£¬Ðí¶àÉúÃü¿ÆÑ§ÁìÓò×îÖØÒªµÄ·¢ÏÖ¶¼·¢±íÔÚ¡¶Ï¸°û¡·ÉÏ¡£11Ô¡¶Ï¸°û¡·Ç°Ê®ÃûÏÂÔØÂÛÎÄΪ£º 1. An Oncogenomics-Based In Vivo RNAi Screen Identifies Tumor Suppressors in Liver Cancer ÃÀ¹úÀäȪ¸ÛʵÑéÊÒ5¸ö²»Í¬µÄС×éÁªºÏ½øÐÐÑо¿£¬Ôڸΰ©Öз¢ÏÖÁË13ÖÖеÄÒÖ°©»ùÒò£¬Ñо¿Ð¡×éµÄºÏ×÷ÌṩÁË´ó¹æÄ£¡¢¿ìËÙ¡¢µÍ»¨·ÑµÄÒÅ´«É¸Ñ¡£¬ÔÚǰÆÚʵÑéÖгɹ¦·¢ÏÖ13ÖÖеÄÒÖ°©»ùÒò¡£ÔÚ°©Ö¢ÓÈÆäÊǸΰ©ÖÐÒÖ°©»ùÒòºÜÖØÒª£¬¾³£»á·¢Ïָΰ©»¼ÕßȱÉÙÁËÒÖ°©»ùÒò¡£ µ±·¢ÉúDNAÍ»±ä¡¢È¾É«ÌåȱʧµÈ¸Ä±äʱÒÖ°©»ùÒò´øÀ´µÄºÃ´¦¿ÉÄܻᶪʧ¡£WiglerС×鼸Äêǰ¿ª·¢³öÒ»ÖÖ¸ßЧ»ùÒò²âÐò¼¼Êõ£¬Ê¹µÃ¼ì²â°©Ï¸°ûÖпÉÄÜ´æÔÚÒÖ°©»ùÒòµÄȱʧȾɫÌ寬¶Î³ÉΪ¿ÉÄÜ¡£ Ñо¿ÈËÔ±¼ì²âÁË100Ãû¸Î°©»¼ÕßµÄȱʧȾɫÌ寬¶Î£¬Æ´³ÉÁËÒ»¶ÎÀíÂÛÉÏ×îÓпÉÄÜ´æÔÚÒÖ°©»ùÒòµÄȾɫÌ寬¶Î¡£Í¨¹ýÓëÕý³£ÈËϸ°ûÖÐȾɫÌåÐòÁеĶԱȣ¬Ñо¿±æÊ¶³öÁËȱʧȾɫÌ寬¶ÎÖеĴóÔ¼300¸ö»ùÒò¡£Ñо¿Ð¡×é²ÉÓÃÁËÐµķ½·¨£¬Í¨¹ýRNA¸ÉÈż¼Êõ£¨RNAi£©À´³ÁÄ¬ÌØ¶¨»ùÒò£¬ÒÔ±æÊ¶»ùÒò¹¦ÄÜ¡£ÕâÒ»·½·¨Óëͨ³£²ÉÓõÄÑо¿Êֶβ»Í¬£¬´ó´óÌá¸ßÁËʱ¼äЧÂÊ¡£ Ñо¿×îºóÈ·ÈÏÁË13ÖÖÐÂÒÖ°©»ùÒò£¬ÆäÖеĴó¶àÊýÈËÃÇ֮ǰ¶¼Ã»ÓÐÒâʶµ½ËüÃǺͰ©Ö¢Óйء£ÂÛÎÄͨѶ×÷Õß¡¢ÀäȪ¸ÛʵÑéÊÒ½ÌÊÚScott W. Lowe±íʾ£º¡°ÕâЩ»ùÒòµÄÐÔÖʲ»ÊǷdz£Ã÷ÏÔ£¬Èç¹ûûÓÐʹÓÃÕâÒ»Ñо¿·½·¨£¬ÎÒÃÇÊÇÎÞ·¨»ñÖªËüÃÇÓë°©Ö¢µÄÁªÏµµÄ¡£ÕâЩ»ùÒòµÄ·¢ÏÖ½«Ôö½øÎÒÃǶ԰©Ö¢µÄÀí½â¡£¡± 2. SIRT1 Redistribution on Chromatin Promotes Genomic Stability but Alters Gene Expression during Aging Ë¥ÀÏÊÇÈ˺Ͷ¯Îï¶¼ÎÞ·¨±ÜÃâµÄÉúÀí¹ý³Ì£¬ÕæºËϸ°ûÔÚË¥ÀϵĹý³ÌÖлùÒò×é»á±äµÃʧȥÎȶ¨ÐÔ£¬»ùÒò±í´ïÒ²»á»ùÒò×éµÄ²»Îȶ¨ÐÔ¶ø·¢Éú¸Ä±ä¡£Ñо¿·¢ÏÖ£¬½Íĸϸ°ûÖеÄ×éµ°°×ÍÑÒÒõ£»ùøSir2¾ßÓгÁĬת¼×ÓºÍÎȶ¨Öظ´DNAµÄ¹¦Ð§£¬µ«ÊÇ£¬µ±Ï¸°û¿ªÊ¼ÀÏ»¯»òÊÇDNA¶ÏÁÑÇé¿ö·¢ÉúµÄʱºò£¬Sir¸´ºÏÎï»áʧȥÔÀ´µÄ¹¦ÄÜ£¬±äµÃ²»¾ßÓгÁĬ»ùÒòµÄÄÜÁ¦£¬²¢×îÖÕµ¼Ö½Íĸʧȥ×ÔÎÒÔöÖ³µÄÄÜÁ¦£¬ÕâÊǽÍĸÀÏ»¯¹ý³ÌÖаéËæ·¢ÉúµÄµäÐÍÌØÕ÷¡£ ΪÁ˽ⲸÈ鶯ÎïÊÇ·ñ¾ßÓÐÏàËÆµÄÇé¿ö£¬Ñо¿ÕßÓÃСÊóÅßÌ¥¸Éϸ°ûÀ´½øÐÐÊÔÑ飬½á¹û·¢ÏÖSIRT1µÄ¹¦ÄÜÓë½ÍĸµÄ Sir2ÏàËÆ£¬SIRT1¾ßÓÐÒÖÖÆÖØ¸´DNAƬ¶Î¸÷ÖÖ»ùÒò±í´ïµÄ¹¦ÄÜ¡£µ±DNA·¢Éú¶ÏÁѵÄÇé¿öʱ£¬SIRT1¾Í»á´Ó»ùÒò×éת×ù×ÓÉϵôÂ䣬²¢ÖØÐ¶¨Î»´Ù½ø DNAÐÞ¸´£¬¸Ä±äת¼¹ý³Ì£¬ÕâÒ»Çé¿öÔÚÀÏ»¯µÄϸ°ûÖÐͬÑù»á³öÏÖ¡£Èç¹ûÔö¼ÓSIRT1µÄ±í´ïÁ¿¿ÉÓÐЧ±£»¤»ùÒò×éÎȶ¨ÐÔÔâÆÆ»µµÄϸ°ûά³Ö»îÐÔ£¬ÒÖÖÆÀÏ»¯´øÀ´µÄ»ùÒò×éת¼±ä»¯¡£ ËùÒÔ˵£¬DNAÔìµ½ÆÆ»µ¿ÉÓÕµ¼SIRT1ÖØÐ·ÖÅ䣬²¢ËæÖ®¸Ä±ä»ùÒò×éµÄת¼Çé¿ö£¬¸Ä±äµ°°×µÄ±í´ïÇé¿ö£¬ÕâÒ»»úÖÆ¿ÉÄÜÊÇÕæºËϸ°ûÔÚÀÏ»¯¹ý³ÌÖÐÒ»¸ö±£ÊصĻúÖÆ¡£ 3. Myosin Vb Mobilizes Recycling Endosomes and AMPA Receptors for Postsynaptic Plasticity ÄÔÈçºÎÐγÉÒ»´Î¼ÇÒ䣿ͨ³££¬ÎÒÃǵľÀúºÍÏ໥×÷ÓûáÒÔijÖÖ·½Ê½ÔÚ´óÄÔÖÐÁôÏÂÀÓÓ¡£¬È»¶øÉñ¾Ï¸°û¾¿¾¹ÊÇÈçºÎ¸Ä±äËüÃǵÄÁ¬½Ó´Ó¶øÐγɼÇÒ䣬ȴһֱÊǸöδ½âÖ®ÃÕ¡£Èç½ñ£¬¿ÆÑ§¼Ò±íʾ£¬ËûÃÇÕÒµ½Á˽«¾ÀúÓëÈÏÖªÁªÏµÆðÀ´µÄ·Ö×Ó»úÖÆ£¬¶øÕâÒ»ÇÐËÆºõÈ«²¿Òª¹é¹¦ÓÚһ̨΢СµÄ·Ö×Ó·¢¶¯»ú¡£ ¿ÆÑ§¼ÒÏàÐÅ£¬¼ÇÒäµÄ´æ´¢ÓëÒ»¸öÃûΪ³¤Ê±³ÌÔöÇ¿£¨LTP£©µÄ¹ý³ÌÓйأ¬¸Ã¹ý³ÌÇ¿»¯ÁËÉñ¾Ï¸°û¶ÔÖ®¼äµÄÁªÏµ¡£Éñ¾Ï¸°ûͨ¹ýÊÍ·ÅÉñ¾´«µÝËØ¡ª¡ªÓÃÓڴ̼¤ÖÜΧ¡°ÁÚ¾Ó¡±µÄÊÜÌ塪¡ªÀ´½øÐн»Á÷£¬¶øLTPÄܹ»´¥·¢¸ü¶àµÄÊÜÌå¾Û¼¯ÔÚ½ÓÊÕϸ°ûµÄϸ°ûĤÉÏ£¬´Ó¶øÊ¹Æä¶ÔÓÚµ½À´µÄÐÅÏ¢¸üΪÃô¸Ð¡£ ֮ǰµÄÑо¿±íÃ÷£¬¼¡¶¯µ°°×ºÍ¼¡Çòµ°°×¡ª¡ªÔÚ¼¡ÈâÊÕËõÖаçÑÝÖØÒª½ÇÉ«µÄÁ½ÖÖµ°°×ÖÊ¡ª¡ªÔÚÉñ¾Ï¸°ûµÄÊÜÌå»ý¾Û¹ý³ÌÖÐÆðµ½Á˹ؼü×÷Óá£ÎªÁËÑо¿ÕâÖÖ¿ÉÄÜÐÔ£¬ÃÀ¹ú±±¿¨ÂÞÀ³ÄÉÖÝ´ïÀÕÄ·Êжſ˴óѧҽѧÖÐÐĵÄÉñ¾ÉúÎïѧ¼ÒMichael EhlersºÍËûµÄͬÊ£¬ÀûÓö¨Ê±³ÉÏñºÍÉúÎﻯѧ·½·¨£¬¶ÔСÊóµÄ´óÄÔÇÐÆ¬½øÐÐÁËÑо¿¡£ÕâЩÊÔÑéÏÔʾ£¬Ò»¸öÒýÈëµÄÐźÅÄܹ»´¥·¢´óÁ¿µÄ¸Æ½øÈëÒ»¸öÉñ¾Ï¸°û¡£ÕâЩ¸Æ»á¼¤»îÒ»ÖÖ¼¡Çòµ°°×¡ª¡ª¼¡Çòµ°°×Vb£¬´Ó¶ø´ÙʹËü»ñµÃ´¢´æÔÚϸ°ûÉî´¦µÄÊÜÌå°ü£¬²¢½«ÕâЩÊÜÌå°ü´øµ½Éñ¾Ï¸°ûµÄÐźÅλµã£¬ÔÚÕâÀÊÜÌåÄܹ»½ÓÊÕÉñ¾´«µÝËØ£¬²¢²ÎÓëLTP¹ý³Ì¡£ Ϊ֤ʵ¼¡Çòµ°°×VbµÄÈ·ÊÇÈÃÈÏÖª¹ý³Ì±äΪ¿ÉÄܵķ¢¶¯»ú£¬EhlersºÍËûµÄͬÊÂÀûÓû¯Ñ§·½·¨ÒÖÖÆÉñ¾Ï¸°ûÖеļ¡Çòµ°°×Vb£¬ÕâЩϸ°ûÓÚÊDZãÎÞ·¨²úÉúLTP¡£Ñо¿ÈËÔ±ÔÚ¡¶Ï¸°û¡·ÔÓÖ¾Éϱ¨¸æÁËÕâÒ»Ñо¿³É¹û¡£EhlersÖ¸³ö£º¡°¶ÔÓÚÒ»¸öÂí´ï·Ö×Ó¾¹È»Äܹ»½âÊÍ´ó¶àÊýµÄĤ´«Êä¹ý³Ì£¬ÎÒÃǸе½·Ç³£¾ªÑÈ¡£ÊÂʵÉÏ£¬ËüºÜ¿ÉÄܾÍÊÇÐγɼÇÒäµÄ¡®·¢¶¯»ú¡¯¡£¡± 4. Telomerase Reverse Transcriptase Delays Aging in Cancer-Resistant Mice ¶ËÁ£Äæ×ªÂ¼Ã¸ÑÓ»º°©Ö¢µÖ¿¹ÐÔÀÏÊóµÄË¥ÀϽø³Ì ¶ËÁ£Ã¸Í¨¹ýÑÓ³¤È¾É«Ìå¶ËλÉϵÄ×ÅË¿µã£¬Îª´ó¶àÊýÈËÀàϸ°ûÌṩÁËÎÞÏÞµÄÔöÖ³ÄÜÁ¦£¬·ñÔòȾɫÌ彫Êܵ½Ëðʧ²¢×îÖÕ½µµÍÔöÖ³ÄÜÁ¦¡£È»¶øÈËÃǶԶËÁ£Ã¸ÔÚÓлúÌåÀÏ»¯Ê±ËùÆðµÄ×÷ÓÃÒ»Ö±²»ÉõÁ˽⣬ÆäÖÐÒ»²¿·ÖÔÒò¾ÍÊǶËÁ£Ã¸Äܹ»´Ùʹ°©Ö¢µÄ·¢Éú¡£ÎªÁËÈÆ¿ªÕâ¸öÎÊÌ⣬ÎÄÕÂ×÷ÕßÔÚͨ¹ý¼ÓÇ¿ÒÖÖÆ°©Ö¢Òò×Óp53¡¢p16ºÍ p19ARF±í´ïËù½¨Á¢µÄ¿¹°©Ð¡ÊóÄ£ÐÍÖУ¬¶Ô¶ËÁ£Ã¸µÄ×é·ÖÖ®Ò»¶ËÁ£Äæ×ªÂ¼Ã¸(TERT)µÄ±í´ï·ÖÎö¡£ÔÚÕâÖÖ±³¾°Ï£¬TERTµÄ¹ýÁ¿±í´ïÄܹ»¸ÄÉÆÓÈÆäÊÇÆ¤·ôºÍС³¦ÉÏÆ¤µÄ·ÀÓùÄÜÁ¦£¬²¢ÄܲúÉúÒ»ÖÖÍÆ³Ùϸ°ûϵͳÀÏ»¯µÄ×÷Óá£ÕâЩÑо¿½á¹û±íÃ÷ÔÚ²¸È鶯ÎïÓлúÌå±³¾°Ï£¬¶ËÁ£Äæ×ªÂ¼Ã¸Äܹ»²úÉú¿¹»úÌåÀÏ»¯µÄ×÷Óᣠ5. N-acylphosphatidylethanolamine, a Gut- Derived Circulating Factor Induced by Fat Ingestion, Inhibits Food Intake N-õ£»ùÁ×Ö¬õ£ÒÒ´¼°·£¨N-acylphosphatidylethanolamines £¬NAPEs£©ÊÇÔÚѪ֬Öк¬Á¿Ïà¶Ô½Ï·á¸»µÄÎïÖÊ£¬µ«ÊÇÒ»Ö±ÒÔÀ´¿ÆÑ§¼ÒÃǶ¼²»Á˽âËüµÄÉúÀí×÷ÓᣠÔÚ±¾Ñо¿ÖУ¬¿ÆÑ§¼ÒÃÇ·¢ÏÖNAPEsÆäʵÊÇС³¦ÔÚÏû»¯Ö¬·¾µÄ¹ý³ÌÖзÖÃÚµÄÒ»ÖÖ»îÐÔÎïÖÊ£¬ÔÚÉúÀí¼ÁÁ¿ÏÂNAPEs¾ßÓнµµÍʳÓû£¬ÒÖÖÆ½øÊ³µÄ¹¦ÄÜ£¬²¢ÇÒͨ¹ý¶¯ÎïʵÑé֤ʵ²»»á²úÉúÌõ¼þÐÔζ¾õÑá¶ñ£¨Ñáʳ£©Çé¿ö¡£ ²¢ÇÒÑо¿ÕßÓÃC14Í¬Î»ËØ±ê¼ÇNAPEs£¬·¢ÏÖNAPEsÔ½¹ýѪÄÔÆÁÕϽøÈë´óÄÔºó£¬ÔÚÏÂÇðÄÔ²¿¼¯ÖÐÆðÀ´£¬ÏÂÇðÄÔ²¿µÄNAPEsŨ¶ÈÉý¸ß£¬´Ì¼¤Éñ¾ÒÖÖÆ½øÊ³¡£ÕâÒ»½á¹û±íÃ÷£¬NAPEs¿ÉÖ±½Ó×÷ÓÃÓÚÖÐÊàÉñ¾ÏµÍ³ÒÖÖÆ½øÊ³¡£ Ñо¿Õß·¢ÏÖ£¬NAPEs¾ßÓг¤Ð§ÒÖÖÆ½øÊ³ºÍÌåÖØÔö¼ÓµÄ¹¦ÄÜ¡£ÕâÒâζ×ÅNAPEsºÍËüµÄͬϵÎï¿ÉÄܳÉΪ·ÊÅÖÖÎÁƵÄаÐλ¡£ 6. Hematopoietic Stem Cells Reversibly Switch from Dormancy to Self-Renewal during Homeostasis and Repair ¹ÇËèÔìѪ¸Éϸ°ûÊÇÉúÎïÌåÄÚά³ÖѪϸ°û¸üеÄÖØÒªÏ¸°ûϵ¡£¾¡¹Ü£¬¹ÇËèÔìѪ¸Éϸ°û·Ö»¯µÄƵÂʺܵͣ¬µ«ÊÇ¿ÆÑ§¼ÒÃÇÈÏΪ¹ÇËèÔìѪ¸Éϸ°û¿â³£ÊýÐÇÆÚ¸üÐÂÒ»´Î£¬Õâ±íÃ÷¹ÇËèÔìѪ¸Éϸ°ûºÜÓйæÂɵؽøÈë»òÊÇÍ˳öϸ°ûÖÜÆÚ¡£ ÔÚ±¾Ñо¿ÖУ¬¿ÆÑ§¼ÒʹÓÃÁ÷ʽϸ°û¼ÆÊý¼¼Êõ£¨´øÓÐBrdU and histone H2B-GFP±êÇ©£©¼ø¶¨³öСÊóµÄÐÝÃß¹ÇËèÔìѪ¸Éϸ°û£¨dormant mouse bone marrow hematopoietic stem cells£¬ d-HSC£©£¬±íÏÖΪlin−Sca1+cKit+CD150+CD48−CD34− ¡£ ÓüÆËã»úÄ£ÐÍÔ¤²âµÃ³ö½áÂÛ£¬ÕâЩÐÝÃߵĹÇËèÔìѪ¸Éϸ°ûÿ145Ìì×ÔÎÒ¸üÐÂÒ»´Î£¬ÔÚËüÕû¸öÉúÃüÖÜÆÚÀï¹²¸üÐÂ5´Î¡£ÐÝÃߵĹÇËèÔìѪ¸Éϸ°û¾ßÓжàÖÖ×ÔÎÒ¸üеĻîÐÔ¡£ÔÚÄÚ»·¾³Î¬³ÖÎȶ¨µÄÇé¿öÏ£¬ÐÝÃߵĹÇËèÔìѪ¸Éϸ°û¼ÌÐø±£³ÖÐÝÃß״̬£¬µ±¹ÇËèÊܵ½ËðÉË»òÊÇÔÚG-CSFµÄ´Ì¼¤Ï£¬¹ÇËèÔìѪ¸Éϸ°ûÓÖ»Ö¸´×ÔÎÒ¸üеĻîÁ¦¡£·Ö»¯³öеÄѪҺϸ°ûά³ÖÄÚ»·¾³µÄÎÈ̬£¬»îÔ¾·Ö»¯ºóµÄÔìѪ¸Éϸ°ûÔÚÉúÃüÖÜÆÚÄÚÔڴ˻ع鵽ÐÝÃß״̬¡£ ÕâЩÑо¿½á¹û±íÃ÷£¬¹ÇËèÔìѪ¸Éϸ°ûÒ»°ã´¦ÓÚÐÝÃß״̬£¬Ö»ÓгöÏÖÔìѪѹÁ¦µÄʱºò²Å»á±»¼¤»î£¬²úÉú×ÔÎÒ¸üеÄÄÜÁ¦¡£ 7. H2AZ Is Enriched at Polycomb Complex Target Genes in ES Cells and Is Necessary for Lineage Commitment ÉúÃüÆðÔ´ÓÚÅßÌ¥¸Éϸ°û£¬ÉúÎïµÄ¶àÑùÐÔÀ´×ÔÓÚ¸Éϸ°ûµÄ¶àÄÜÐÔ¡£ÅßÌ¥¸Éϸ°ûµÄ·¢ÓýÊÇÒ»¸ö¸´ÔÓµÄÉúÀí¹ý³Ì£¬ÔÚÅßÌ¥¸Éϸ°ûµÄ·Ö»¯·¢Óý¹ý³ÌÖÐÊܶà¸ö»ùÒòµÄµ÷¿Ø£¬ÕâÒ»¹ý³ÌÒ²Ò»Ö±ÊÇ¿ÆÑ§¼ÒÃÇØ½´ýÁ˽âµÄÉñÃØ¹ý³Ì¡£ÓÈÆäÊǶÔÅßÌ¥¸Éϸ°ûµÄÁ˽âÓÐÖúÓÚÁ˽âÈËÀ༲²¡µÄ·¢Éú·¢Õ¹»úÖÆ¡£Òò´Ë£¬¸Éϸ°û·¢ÓýÓë»ùÒòµ÷½ÚµÄ¹ØÏµ¾Í³ÉΪÑо¿Õß²»Ð¸Å¬Á¦µÄ·½Ïò¡£ Ñо¿·¢ÏÖ£¬±äÒìµÄ×éµ°°×H2AZÔÚȾɫÖʹ¦Äܵķ¢Óý¹ý³ÌÖÐÊÇÒ»¸ö¹Ø¼üµÄµ÷¿ØÒò×Ó£¬¶Ô»ùÒò±í´ïµÈ¹¦ÄÜÆäÖØÒªµÄ×÷Ó㬵«ÊÇÈËÃÇȴһֱûÓнҿªH2AZ×éµ°°×µÄÉñÃØÃæÉ´£¬¾¿¾¹ËüÊÇÈçºÎ·¢»Ó×÷Óã¬ÈËÃÇÒ»ÎÞËùÖª¡£ ÔÚ±¾ÎÄÕÂÖУ¬ÂéÊ¡Àí¹¤ºÍ¹þ·ð°×Í·Ñо¿ËùµÄ¿ÆÑ§¼Ò½«´Ó»ùÒò×éѧµÄˮƽ·ÖÎöH2AZ£¬ÐµÄÑо¿½á¹û±íÃ÷H2AZµÄ×÷ÓÃģʽÓëPcG£¨Polycomb group£©µ°°×Suz12¾ªÈ˵ÄÏàËÆ£¬ËüÃÇÊÇÄ³Ð©ÖØÒªµÄ»ùÒòµÄÆô¶¯×Óµ°°×¡£ 8. The Growth Factor Environment Defines Distinct Pluripotent Ground States in Novel Blastocyst-Derived Stem Cells ϸ°û¾ßÓжàÄÜÐÔ£¬ÕâÊÇÒ»ÖÖά³Öϸ°û×ÔÎÒ¸üÐÂÒÔ¼°²úÉúÈýÅß²ãÑÜÉú×éÖ¯µÄÄÜÁ¦¡£³¤¾ÃÒÔÀ´¿ÆÑ§¼ÒÃÇÒ»Ö±ÈÏΪ£¬¸Éϸ°û¶àÄÜÐÔÊÇÒ»ÖÖµ¥Ò»µÄ¸ß½×»ù̬£¬²¢ÇÒËæ×Åϸ°û·Ö»¯µÄ¿ªÊ¼¶øÖð²½É¥Ê§¡£¶øÔÚ2008Äê10ÔÂ31ÈÕ³ö°æµÄ¡¶Ï¸°û¡·ÉÏ£¬À´×ÔÃÀ¹úÂéÊ¡×ÛºÏÒ½ÔºµÄYu-Fen ChouµÈ¿ÆÑ§¼ÒÈÏΪ£¬ÊÂʵÉÏ´æÔÚ¶à¸öÕâÑùµÄ»ù̬£¬Ã¿Ò»¸ö»ù̬¶¼¾ßÓÐ×ÔÉí¶ÀÌØµÄ·Ö×ÓºÍÉúÎïÑ§ÌØÐÔ¡£ Ñо¿Ð¡×éÖ¤Ã÷Á˸Éϸ°ûÄÜ´ÓÒ»¸ö̬ת»¯µ½ÁíÒ»¸ö̬£¬¶øÒÔÉϹý³ÌºÜ´ó³Ì¶ÈÉÏÈ¡¾öÓÚϸ°ûÉú³¤Òò×Ó΢»·¾³¡£¶àÄܸÉϸ°ûϵ£¨pluripotent stem cell line£©ÄÜÓÉÄÒÅß²úÉú£¬ÕâÒ»²¿·Ö×îÖյõ½ÅßÌ¥¸Éϸ°ûϵ£¨embryonic stem cell line£¬ES cell line£©£¬¶øÁíÒ»²¿·Ö¶àÄܸÉϸ°ûÀ´×ÔÓÚÉÏÅ߲㣬Õⲿ·Ö×îÖյõ½ÉÏÅß²ã¸Éϸ°ûϵ£¨epiblast stem cell line£¬EpiSCs line£©¡£¶øESϸ°ûÒÔ¼°EpiSCsϸ°ûÔÚ½áºÏά³ÖÆä¶àÄÜ״̬µÄÉú³¤Òò×Óʱ±íÏÖ³ö¼«´óµÄ²îÒì¡£ÕâÁ½ÖÖ¸Éϸ°ûÖÖÀàµÄ·Ö×ÓÒÔ¼°¹¦ÄÜÉϵIJî±ðÖ¤Ã÷£¬×éÖ¯À´Ô´ºÍÉú³¤Òò×Ó»·¾³»òÐí¶ÔÓÚ¾ö¶¨¸Éϸ°ûÀàÐͷdz£ÖØÒª¡£ 9. Real-Time Redox Measurements during Endoplasmic Reticulum Stress Reveal Interlinked Protein Folding Functions ÄÚÖÊÍøÓ°Ïìµ°°×ÕÛµþ¹¦ÄܵÄʵʱÑõ»¯»¹Ô²â¶¨ ¶ÔÄÚÖÊÍø£¨ER£©µ°°×ÖÊÕÛµþµÄÆÆ»µ£¬Äܵ¼ÖÂδÕÛµþµ°°×µÄ¶Ñ»ý£¬´Ó¶øÒý·¢Æä²úÉúÓ¦´ð(UPR)¡£Ïà·´£¬UPRµÄ¼õÉÙ¿ÉʹERδÕÛµþµ°°×½Ó½ü¸º·´À¡»ØÂ·¡£µ«ÊÇ£¬ÓÉÓÚÎÞ·¨²âÁ¿µ½ÌåÄÚδÕÛµþµ°°×µÄŨ¶È£¬ËùÒÔÎÞÂÛUPRÈçºÎÔË×÷£¬¶¼±»ÈÏΪÊÇ¡°ERµÄ¹¦ÀÍ¡±¡£ÒòΪERÑõ»¯»¹ÔµçλÓëÑõ»¯µÄµ°°×ÕÛµþ×îÏàÅ䣬ËùÒÔÑо¿ÈËÔ±ÍÆ¶Ïͨ¹ýÑõ»¯»¹ÔÁ¿µÄ¼ì²â£¬Äܹ»µÃ֪δÕÛµþµ°°×µÄ»ýÀÛÁ¿¡£ÎªÁËÑéÖ¤ÕâÒ»Ïë·¨£¬Ñо¿ÈËÔ±ÀûÓÃÓ«¹âµ°°×¼¼Êõ£¬¶ÔERÑõ»¯»¹Ô״̬ºÍµ¥Ò»Ï¸°ûÖÐERµÄ»î¶¯½øÐÐÁ˶¯Ì¬¼à²â¡£Í¨¹ýÕâЩÊֶΣ¬×¨¼ÒÃÇ·¢ÏÖÁ˲»Í¬µÄѹÁ¦ÒòËØ£¬°üÀ¨ÊµÑéÐԵĺÍÉúÀíѧÉϵģ¬ÕâЩÒòËØÔÚµ±UPRÇ¿ÖÆÄÚÆ½ºâ¿ØÖÆÊ§Ð§Ê±£¬ÄÜʹERµ°°×±»Ñõ»¯¡£Í¨¹ý»ùÒò·ÖÎö£¬Ñо¿ÈËÔ±½ÒʾÁ˵ȻùÒòϸ°ûȺÖÐÑõ»¯»¹ÔµÄÒìÖÊÐÔ£¬²¢ÏÔʾÁËERµ°°×ÕÛµþ¡¢ÐÞÊκÍÖÊÁ¿¿ØÖÆÏµÍ³¹¦ÄܼäµÄÁªÏµ¡£ 10. Lrp5 Controls Bone Formation by Inhibiting Serotonin Synthesis in the Duodenum Lrp5Ó°Ïì¹ÇÖʵÄ;¾¶ Lrp5»ùÒò±í´ïµÄȱʧ»òÔö¼ÓÓ°Ïì׏Ç÷ÀµÄÐγɣ¬Äܹ»µ¼Ö¹ÇÖÊÊèËɺ͹ÇÖÊÔöÉú¡£ËäÈ»Lrp5±»ÊÓΪWntÐźÅÊÜÌ壬µ«ÊǦÂ-µ°°×µÄ³É¹Çϸ°ûÌØ¶¨·ÖÁѲ»»áÓ°Ïì¹Ç÷ÀµÄÐγɡ£Ïà·´µÄ£¬×÷ÕßΪÎÒÃÇչʾÁË£¬Lrp5Äܹ»ÒÖÖÆTph1µÄ±í´ï¡£Tph1ÊÇÊ®¶þÖ¸³¦Êȸõϸ°ûµÄÏÞËÙø¡£Òò´Ë£¬½µµÍѪҺôÇÉ«°·Ë®Æ½Äܹ»»Ø¸´Lrp5ȱÏÝСÊóµÄ¹Ç÷ÀÐγɺÍÖÊÁ¿¡£´ËÍ⣬³¦Lrp5µÄÌØ¶¨¼¤»î»òTph1µÄÃð»î£¬Äܹ»Ôö¼Ó¹ÇÖÊÃܶȣ¬·±Ö³Âѳ²ÇгýºóÒý·¢µÄ¹ÇÖʶªÊ§¡£ÑªÇåËØÍ¨¹ýHtr1bÊÜÌåºÍÁ×Ëữ×÷ÓÃÒÖÖÆ³É¹Çϸ°ûµÄÀ©É¢¡£´ËÏîÑо¿À©Õ¹ÁËÎÒÃǶԹÇÖÊÖØ½¨µÄÁ˽⣬ÓÐÖúÓÚ¶ÔÏà¹ØÒ½ÁÆ·½·¨µÄÑо¿¡££¨À´Ô´£ºÉúÎïͨ£© |
2Â¥2009-01-09 19:03:56
zhwenxing
ľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 11 (СѧÉú)
- ¹ó±ö: 0.005
- ½ð±Ò: 2189.8
- Ìû×Ó: 1324
- ÔÚÏß: 93.3Сʱ
- ³æºÅ: 596551
3Â¥2009-01-09 19:05:46
6Â¥2009-01-10 08:59:28













»Ø¸´´ËÂ¥
